MDM2 Knockdown Reduces the Oncogenic Activities and Enhances NIS Protein Abundance in Papillary Thyroid Cancer.

IF 2.6 4区 医学 Q2 GENETICS & HEREDITY
Daniel Hueng-Yuan Shen, Hung-Ping Chan, Fu-Ren Tsai, Yu-Li Chiu, Tsung-Jung Liang, Yunying She, An-Chi Liu, Hui-Ying Yeh, Kuo-Wang Tsai, Sung-Chou Li
{"title":"<i>MDM2</i> Knockdown Reduces the Oncogenic Activities and Enhances NIS Protein Abundance in Papillary Thyroid Cancer.","authors":"Daniel Hueng-Yuan Shen, Hung-Ping Chan, Fu-Ren Tsai, Yu-Li Chiu, Tsung-Jung Liang, Yunying She, An-Chi Liu, Hui-Ying Yeh, Kuo-Wang Tsai, Sung-Chou Li","doi":"10.21873/cgp.20512","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Despite the excellent prognosis post thyroidectomy and radioiodine therapy, papillary thyroid cancer (PTC) patients still undergo dismal outcomes, especially when tumors undergo de-differentiation and thus progress to radioiodine refractory status. Our knowledge on the pathogenesis mechanisms of PTC and NIS protein (responsible for iodine uptake) activity is still behind satisfaction. To increase our knowledge on these issues, we conducted this study.</p><p><strong>Materials and methods: </strong>We analyzed microarray data to identify the genes differentially expressed between normal and tumor thyroid tissues. Next, pathway enrichment analysis was conducted to derive candidate genes and pathways involved in PTC oncogenesis and NIS activity. The expression of candidate genes was confirmed by an independent TCGA dataset. Then, we used siRNA to knockdown the <i>MDM2</i> gene to examine the potential pathogenesis mechanisms of <i>MDM2</i> and <i>MDM2</i>-P53-NIS axis in cells. Also, we examined whether oncogenic activities, including cell proliferation, colony formation, cell migration and cell invasion, were altered with <i>MDM2</i> knockdown. Moreover, NIS protein intensity in cell membrane was also investigated.</p><p><strong>Results: </strong>Through analyzing microarray data, pathway enrichment and correlation analyses, we focused on <i>MDM2</i> since it could be involved in the <i>MDM2</i>-P53-NIS axis. Knockdown of <i>MDM2</i> significantly reduced the mRNA levels and protein abundance of <i>MDM2</i>. In addition, P53 protein was also elevated with <i>MDM2</i> knockdown. With <i>MDM2</i> knockdown, cell proliferation and colony formation were repressed. And, both cell migration and invasion abilities were interfered. Moreover, <i>MDM2</i> knockdown also enhanced the intensity of membrane NIS protein.</p><p><strong>Conclusion: </strong><i>MDM2</i> knockdown not only reduced the oncogenic activities of thyroid cancer but also enhanced the intensity of NIS protein responsible for iodine intake in thyroid gland. Therefore, <i>MDM2</i> could serve as a prognosis indicator in thyroid cancer.</p>","PeriodicalId":9516,"journal":{"name":"Cancer Genomics & Proteomics","volume":"22 3","pages":"444-457"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041878/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Genomics & Proteomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/cgp.20512","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: Despite the excellent prognosis post thyroidectomy and radioiodine therapy, papillary thyroid cancer (PTC) patients still undergo dismal outcomes, especially when tumors undergo de-differentiation and thus progress to radioiodine refractory status. Our knowledge on the pathogenesis mechanisms of PTC and NIS protein (responsible for iodine uptake) activity is still behind satisfaction. To increase our knowledge on these issues, we conducted this study.

Materials and methods: We analyzed microarray data to identify the genes differentially expressed between normal and tumor thyroid tissues. Next, pathway enrichment analysis was conducted to derive candidate genes and pathways involved in PTC oncogenesis and NIS activity. The expression of candidate genes was confirmed by an independent TCGA dataset. Then, we used siRNA to knockdown the MDM2 gene to examine the potential pathogenesis mechanisms of MDM2 and MDM2-P53-NIS axis in cells. Also, we examined whether oncogenic activities, including cell proliferation, colony formation, cell migration and cell invasion, were altered with MDM2 knockdown. Moreover, NIS protein intensity in cell membrane was also investigated.

Results: Through analyzing microarray data, pathway enrichment and correlation analyses, we focused on MDM2 since it could be involved in the MDM2-P53-NIS axis. Knockdown of MDM2 significantly reduced the mRNA levels and protein abundance of MDM2. In addition, P53 protein was also elevated with MDM2 knockdown. With MDM2 knockdown, cell proliferation and colony formation were repressed. And, both cell migration and invasion abilities were interfered. Moreover, MDM2 knockdown also enhanced the intensity of membrane NIS protein.

Conclusion: MDM2 knockdown not only reduced the oncogenic activities of thyroid cancer but also enhanced the intensity of NIS protein responsible for iodine intake in thyroid gland. Therefore, MDM2 could serve as a prognosis indicator in thyroid cancer.

MDM2敲低可降低甲状腺乳头状癌的致癌活性并提高NIS蛋白的丰度。
背景/目的:尽管甲状腺切除术和放射性碘治疗后预后良好,但乳头状甲状腺癌(PTC)患者的预后仍然很差,特别是当肿瘤发生去分化,从而进展到放射性碘难治性状态时。我们对PTC和NIS蛋白(负责碘摄取)活性的发病机制的了解仍然落后于满意。为了增加我们对这些问题的认识,我们进行了这项研究。材料和方法:我们分析了微阵列数据,以确定正常和肿瘤甲状腺组织之间的基因差异表达。接下来,进行途径富集分析,以获得参与PTC肿瘤发生和NIS活性的候选基因和途径。候选基因的表达通过独立的TCGA数据集进行确认。然后,我们利用siRNA敲低MDM2基因,研究MDM2和MDM2- p53 - nis轴在细胞中的潜在发病机制。此外,我们还研究了MDM2敲低是否会改变致癌活性,包括细胞增殖、集落形成、细胞迁移和细胞侵袭。此外,还研究了细胞膜上NIS蛋白的表达强度。结果:通过分析芯片数据、通路富集和相关分析,我们将重点放在MDM2上,因为它可能参与MDM2- p53 - nis轴。敲低MDM2显著降低MDM2 mRNA水平和蛋白丰度。此外,P53蛋白也随着MDM2的下调而升高。MDM2敲低后,细胞增殖和集落形成受到抑制。细胞的迁移和侵袭能力均受到干扰。此外,MDM2敲低也增强了膜NIS蛋白的强度。结论:MDM2基因敲低不仅降低了甲状腺癌的致癌活性,而且增加了甲状腺中负责碘摄入的NIS蛋白的强度。因此,MDM2可作为甲状腺癌的预后指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Genomics & Proteomics
Cancer Genomics & Proteomics ONCOLOGY-GENETICS & HEREDITY
CiteScore
5.00
自引率
8.00%
发文量
51
期刊介绍: Cancer Genomics & Proteomics (CGP) is an international peer-reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising. The first issue of CGP circulated in January 2004. Cancer Genomics & Proteomics is a journal of the International Institute of Anticancer Research. From January 2013 CGP is converted to an online-only open access journal. Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信